Clinical Trials Browser

OTHER × ibrutinib × Tumor-Agnostic × Clear all

NCT03525925 2024-03-18

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Phase 1 Completed

Neoplasm Metastasis